Product image of Lipenil (Simvastatin) supplied by GNH India

Lipenil

Active Ingredient:
Simvastatin
Origin:
EU

Lipenil (Simvastatin)

Simvastatin, the active ingredient in Lipenil, is a HMG‑CoA reductase inhibitor presented as an oral tablet for oral use. It lowers elevated cholesterol levels and is used to manage hypercholesterolemia and reduce cardiovascular risk in adults. It is indicated for primary hyperlipidemia and for the primary prevention of cardiovascular events in patients with established risk factors.

GNH India supplies Lipenil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable global distribution.

Manufacturer / TM Owner

S.F. Group Srl

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Simvastatin acts on lipid metabolism to lower cholesterol levels.
  • Hypercholesterolemia: reduces low‑density lipoprotein cholesterol (LDL‑C) and total cholesterol.
  • Primary hyperlipidemia: improves overall lipid profile including triglycerides and HDL‑C.
  • Prevention of cardiovascular disease: lowers the risk of myocardial infarction, stroke and related cardiovascular events in at‑risk adults.

How It Works

  • Simvastatin is a pro‑drug that is converted in the liver to its active hydroxy acid form, which competitively inhibits HMG‑CoA reductase, the key enzyme in the mevalonate pathway of cholesterol synthesis. This inhibition reduces hepatic cholesterol production, up‑regulates LDL receptors on hepatocyte surfaces, and enhances clearance of circulating LDL particles, thereby lowering plasma cholesterol levels.

Side Effects

Simvastatin may cause a range of adverse reactions.

Common Side Effects

  • Headache: mild to moderate frequency.
  • Myalgia or muscle pain: often transient.
  • Abdominal discomfort: including dyspepsia.
  • Nausea: occasional.
  • Constipation: mild.
  • Elevated liver enzymes: asymptomatic.

Serious or Rare Side Effects

  • Rhabdomyolysis: severe muscle breakdown.
  • Acute liver injury: jaundice or hepatitis.
  • Severe allergic reactions: rash, angioedema.
  • Myopathy: significant muscle weakness.
  • Pancreatitis: abdominal pain with elevated enzymes.
  • Hepatitis: inflammation of the liver.

Precautions & Warnings

  • Before initiating therapy, consider the following precautions.
  • Liver function monitoring: assess baseline transaminases and repeat periodically.
  • Drug interaction review: evaluate concomitant medications that affect CYP3A4.
  • Renal function assessment: adjust use in severe renal impairment.
  • Pregnancy contraindication: avoid in pregnant or nursing women.
  • Elderly caution: start at lower dose and monitor tolerance.
  • Store at ambient temperature: keep in the original container, protect from moisture and light.

Avoid Interactions

Simvastatin interacts with several medicines; categorisation helps manage risk.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., itraconazole, clarithromycin): can markedly increase plasma simvastatin levels.
  • Gemfibrozil: raises risk of myopathy and rhabdomyolysis.
  • High‑dose niacin: enhances muscle toxicity.

Moderate Interactions (Monitor Closely)

  • Amiodarone: may increase simvastatin concentrations.
  • Warfarin: potential for altered anticoagulant effect.
  • Digoxin: possible increase in serum digoxin levels.

Frequently Asked Questions

Lipenil contains simvastatin, which is prescribed to lower elevated cholesterol and triglyceride levels. It is used in adults with hypercholesterolemia, primary hyperlipidemia, and for the primary prevention of cardiovascular events such as heart attacks and strokes.

Simvastatin is converted in the liver to its active form, which competitively inhibits the enzyme HMG‑CoA reductase. This blockage reduces the synthesis of cholesterol, leading to up‑regulation of LDL receptors and increased clearance of LDL‑C from the bloodstream.

The appropriate dose of Lipenil is determined by the prescribing clinician based on the patient’s cholesterol levels, overall cardiovascular risk, age, and any concomitant medications. Dosage adjustments are made according to clinical response and safety monitoring.

Simvastatin, the active ingredient in Lipenil, is contraindicated in pregnancy and breastfeeding because it may harm the developing fetus or infant. Women who are pregnant, planning to become pregnant, or nursing should not use this medication.

To order Lipenil, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Lipenil (simvastatin) belongs to the statin class, which is generally more potent at reducing LDL‑C than older agents such as bile‑acid sequestrants. Compared with newer, higher‑potency statins, simvastatin may require higher doses to achieve similar LDL reductions but has an established safety profile.

Lipenil should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the tablets away from moisture, direct sunlight and excessive heat to maintain product stability.

Lipenil is taken orally, usually once daily in the evening, with or without food as directed by the prescriber. Swallow the tablet whole with a glass of water; do not crush or chew it.

The most serious risks include rhabdomyolysis (severe muscle breakdown), acute liver injury, and severe allergic reactions. Patients should report unexplained muscle pain, weakness, dark urine, or signs of liver dysfunction such as jaundice promptly.

Lipenil should not be used by individuals with active liver disease, unexplained persistent elevations of hepatic transaminases, known hypersensitivity to simvastatin, or women who are pregnant or breastfeeding. It is also contraindicated in patients taking certain strong CYP3A4 inhibitors.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Simvastatin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT